UVV

UVV
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $754.177M ▲ | $72.181M ▼ | $34.169M ▲ | 4.531% ▲ | $1.36 ▲ | $81.459M ▲ |
| Q1-2026 | $593.762M ▼ | $80.022M ▲ | $8.497M ▼ | 1.431% ▲ | $0.34 ▼ | $52.443M ▼ |
| Q4-2025 | $702.279M ▼ | $72.142M ▼ | $9.338M ▼ | 1.33% ▼ | $0.37 ▼ | $55.646M ▼ |
| Q3-2025 | $937.193M ▲ | $89.512M ▲ | $59.639M ▲ | 6.364% ▲ | $2.39 ▲ | $118.742M ▲ |
| Q2-2025 | $710.762M | $74.409M | $25.94M | 3.65% | $1.04 | $83.131M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $88.652M ▼ | $3.07B ▼ | $1.566B ▼ | $1.47B ▲ |
| Q1-2026 | $178.435M ▼ | $3.189B ▲ | $1.69B ▲ | $1.459B ▲ |
| Q4-2025 | $260.115M ▲ | $2.99B ▼ | $1.489B ▼ | $1.459B ▲ |
| Q3-2025 | $215.108M ▲ | $3.04B ▼ | $1.549B ▼ | $1.451B ▲ |
| Q2-2025 | $80.118M | $3.046B | $1.588B | $1.421B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $40.673M ▲ | $32.745M ▲ | $-8.308M ▲ | $-114.057M ▼ | $-89.783M ▼ | $23.699M ▲ |
| Q1-2026 | $8.497M ▼ | $-205.103M ▼ | $-11.91M ▼ | $134.622M ▲ | $-81.68M ▼ | $-217.156M ▼ |
| Q4-2025 | $9.338M ▼ | $158.746M ▼ | $-5.968M ▲ | $-108.067M ▼ | $45.007M ▼ | $151.03M ▼ |
| Q3-2025 | $67.796M ▲ | $215.641M ▲ | $-15.466M ▲ | $-64.457M ▼ | $134.99M ▲ | $199.552M ▲ |
| Q2-2025 | $33.969M | $15.031M | $-15.502M | $-21.465M | $-21.582M | $-1.016M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Food Ingredient Sales | $80.00M ▲ | $90.00M ▲ | $80.00M ▼ | $90.00M ▲ |
Product and Service Other | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $10.00M ▼ |
Service Other | $20.00M ▲ | $20.00M ▲ | $30.00M ▲ | $20.00M ▼ |
Tobacco Sales | $810.00M ▲ | $560.00M ▼ | $460.00M ▼ | $620.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Universal looks like a classic mature cash‑generating business in transition. The legacy tobacco operations provide scale, relationships, and relatively steady earnings, but they sit in a structurally challenged, slow‑decline industry with rising regulatory and ESG scrutiny. Financially, revenue and operating profit have grown modestly, while net income has been flatter, leverage has gradually increased, and cash flow has been somewhat volatile but recently improving. Strategically, management is using the stability of the tobacco business to build a second pillar in plant‑based ingredients, backed by targeted acquisitions, process innovation, and sustainability initiatives. The long‑term story hinges on how successfully the company can grow and integrate this newer segment while maintaining discipline around debt levels and cash generation from its legacy core.
NEWS
November 26, 2025 · 12:27 PM UTC
Franklin Universal Trust (“FT” or the “Fund”) Announces Notification of Sources of Distributions
Read more
November 19, 2025 · 4:30 PM UTC
Universal Safety Products, Inc. Reports Second-Quarter Results
Read more
November 19, 2025 · 4:03 PM UTC
Universal Technical Institute Reports Fiscal Year 2025 Fourth Quarter and Year-End Results
Read more
November 18, 2025 · 9:15 AM UTC
Universal Technical Institute, Inc. Announces Multiple New Campus Locations to Address America's Shortage of Skilled Workers
Read more
November 17, 2025 · 8:30 AM UTC
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
Read more
About Universal Corporation
https://www.universalcorp.comUniversal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in the procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $754.177M ▲ | $72.181M ▼ | $34.169M ▲ | 4.531% ▲ | $1.36 ▲ | $81.459M ▲ |
| Q1-2026 | $593.762M ▼ | $80.022M ▲ | $8.497M ▼ | 1.431% ▲ | $0.34 ▼ | $52.443M ▼ |
| Q4-2025 | $702.279M ▼ | $72.142M ▼ | $9.338M ▼ | 1.33% ▼ | $0.37 ▼ | $55.646M ▼ |
| Q3-2025 | $937.193M ▲ | $89.512M ▲ | $59.639M ▲ | 6.364% ▲ | $2.39 ▲ | $118.742M ▲ |
| Q2-2025 | $710.762M | $74.409M | $25.94M | 3.65% | $1.04 | $83.131M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $88.652M ▼ | $3.07B ▼ | $1.566B ▼ | $1.47B ▲ |
| Q1-2026 | $178.435M ▼ | $3.189B ▲ | $1.69B ▲ | $1.459B ▲ |
| Q4-2025 | $260.115M ▲ | $2.99B ▼ | $1.489B ▼ | $1.459B ▲ |
| Q3-2025 | $215.108M ▲ | $3.04B ▼ | $1.549B ▼ | $1.451B ▲ |
| Q2-2025 | $80.118M | $3.046B | $1.588B | $1.421B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $40.673M ▲ | $32.745M ▲ | $-8.308M ▲ | $-114.057M ▼ | $-89.783M ▼ | $23.699M ▲ |
| Q1-2026 | $8.497M ▼ | $-205.103M ▼ | $-11.91M ▼ | $134.622M ▲ | $-81.68M ▼ | $-217.156M ▼ |
| Q4-2025 | $9.338M ▼ | $158.746M ▼ | $-5.968M ▲ | $-108.067M ▼ | $45.007M ▼ | $151.03M ▼ |
| Q3-2025 | $67.796M ▲ | $215.641M ▲ | $-15.466M ▲ | $-64.457M ▼ | $134.99M ▲ | $199.552M ▲ |
| Q2-2025 | $33.969M | $15.031M | $-15.502M | $-21.465M | $-21.582M | $-1.016M |
Revenue by Products
| Product | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|
Food Ingredient Sales | $80.00M ▲ | $90.00M ▲ | $80.00M ▼ | $90.00M ▲ |
Product and Service Other | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $10.00M ▼ |
Service Other | $20.00M ▲ | $20.00M ▲ | $30.00M ▲ | $20.00M ▼ |
Tobacco Sales | $810.00M ▲ | $560.00M ▼ | $460.00M ▼ | $620.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Universal looks like a classic mature cash‑generating business in transition. The legacy tobacco operations provide scale, relationships, and relatively steady earnings, but they sit in a structurally challenged, slow‑decline industry with rising regulatory and ESG scrutiny. Financially, revenue and operating profit have grown modestly, while net income has been flatter, leverage has gradually increased, and cash flow has been somewhat volatile but recently improving. Strategically, management is using the stability of the tobacco business to build a second pillar in plant‑based ingredients, backed by targeted acquisitions, process innovation, and sustainability initiatives. The long‑term story hinges on how successfully the company can grow and integrate this newer segment while maintaining discipline around debt levels and cash generation from its legacy core.
NEWS
November 26, 2025 · 12:27 PM UTC
Franklin Universal Trust (“FT” or the “Fund”) Announces Notification of Sources of Distributions
Read more
November 19, 2025 · 4:30 PM UTC
Universal Safety Products, Inc. Reports Second-Quarter Results
Read more
November 19, 2025 · 4:03 PM UTC
Universal Technical Institute Reports Fiscal Year 2025 Fourth Quarter and Year-End Results
Read more
November 18, 2025 · 9:15 AM UTC
Universal Technical Institute, Inc. Announces Multiple New Campus Locations to Address America's Shortage of Skilled Workers
Read more
November 17, 2025 · 8:30 AM UTC
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
Read more

CEO
Preston Douglas Wigner
Compensation Summary
(Year 2025)

CEO
Preston Douglas Wigner
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1992-01-02 | Forward | 2:1 |
| 1984-03-02 | Forward | 2:1 |
| 1978-03-06 | Forward | 2:1 |
| 1975-11-12 | Forward | 2:1 |
Ratings Snapshot
Rating : B+
Institutional Ownership

BLACKROCK INC.
3.776M Shares
$199.208M

BLACKROCK, INC.
3.692M Shares
$194.794M

VANGUARD GROUP INC
2.948M Shares
$155.558M

BLACKROCK FUND ADVISORS
1.839M Shares
$97.034M

DIMENSIONAL FUND ADVISORS LP
1.782M Shares
$94.011M

STATE STREET CORP
1.449M Shares
$76.451M

INVESCO LTD.
815.801K Shares
$43.042M

GEODE CAPITAL MANAGEMENT, LLC
618.537K Shares
$32.634M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
591.313K Shares
$31.198M

BARCLAYS PLC
578.564K Shares
$30.525M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
544.126K Shares
$28.708M

QUBE RESEARCH & TECHNOLOGIES LTD
463.805K Shares
$24.47M

MORGAN STANLEY
367.714K Shares
$19.401M

BANK OF NEW YORK MELLON CORP
362.705K Shares
$19.136M

PZENA INVESTMENT MANAGEMENT LLC
337.504K Shares
$17.807M

PRUDENTIAL FINANCIAL INC
298.1K Shares
$15.728M

MILLENNIUM MANAGEMENT LLC
279.058K Shares
$14.723M

MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.
273.496K Shares
$14.43M

TWO SIGMA INVESTMENTS, LP
257.345K Shares
$13.578M

NORTHERN TRUST CORP
253.041K Shares
$13.35M
Summary
Only Showing The Top 20

